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Banana including dessert banana and cooking banana, is the second largest produced fruit 
after citrus. Banana peel as by-product, which is about 35% of the total fresh weight, usually 
used as organic fertilizer or simply discarded as waste. Many reports have shown that banana 
peel is an important resource which contains many kinds of nutrients and active components. 
These active components have been reported to exert multiple bioactivities, such as 
antihyperglycemic activity. Diabetes mellitus which is mainly divided into type 1 and type 2, 
has been becoming an important global health problem. Under most circumstances, the current 
antidiabetic medicines are often responsible for various side effects which means that we need 
to develop less toxicity and side effects natural compounds. Triterpenes are good candidates 
that have shown the antihyperglycemic activity with several mechanisms. Banana peels are rich 
in triterpenes with cycloeucalenone and 31-norcyclolaudenone as the major components. The 
purpose of this research is to develop potential antidiabetic natural compounds in banana peel 
and take full advantage of banana peel resource by investigating the antihyperglycemic activity 
of its main triterpenes. 
In chapter 2, four compounds were purified from banana peel ethyl acetate extract by 
HPLC based on the proton NMR. Compound 1 (Fr. 2-2-1) maybe 31-norcyclolaudenone and 
its recovery rate is 0.17%. Compound 2 (Fr. 2-2-2) maybe cycloeucalenone and its recovery 
rate is 0.52%. Compound 3 (Fr. 3-3-3-2-1) maybe the isomer of cycloeucalenol and its recovery 
rate is 0.005%. Compound 4 (Fr. 3-3-3-2-2) maybe cycloeucalenol and its recovery rate is 
0.014%. 
In chapter 3, the structures of four purified compounds were analyzed and confirmed by 
1D and 2D NMR. Based on the 1H and 13C along with COSY, HMQC, HMBC, DEPT 90, DEPT 
135 and comparison with literature data, compound 1 is 31-norcyclolaudenone (isoCE-one), 
compound 2 is cycloeucalenone (CE-one), compound 3 is isomer of cycloeucalenol (isoCE-ol), 
compound 4 is cycloeucalenol (CE-ol). The structural differences of these four triterpenes are 
the carbonyl group or hydroxy group at C-3 and the position of double bond (Δ25(27) or 
Δ24(28)) in the side chain. 
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In chapter 4, the α-glucosidase and α-amylase inhibitory activities of four triterpenes were 
measured and compared in vitro. And their structure-activity relationships were analyzed. In 
addition, the kinetic analysis of CE-one in α-glucosidase inhibitory assay was also elucidated. 
CE-one and isoCE-one exhibited both α-glucosidase and α-amylase inhibitory activities. And 
CE-one showed higher α-glucosidase and α-amylase inhibitory activities than that of isoCE-
one. In contrast, CE-ol and isoCE-ol had insufficient inhibitory activity against either enzyme. 
The IC50 values of CE-one and isoCE-one against α-glucosidase were 31.83 ± 2.46 μM and 
38.85 ± 1.54 μM, respectively, and their IC50 values against α-amylase were 20.33 ± 0.59 μM 
and 27.63 ± 0.83 μM, respectively. The main active sites of CE-one and isoCE-one are the 
carbonyl group at C-3 and double bond in the side chain. And CE-one induced a parabolic 
mixed-type inhibition with the Ki value of 73.86 μM in α-glucosidase inhibitory assay.  
In chapter 5, the carbohydrate-loading tests of CE-one in normal mice and the 
antihyperglycemic activity of CE-one in STZ-induced diabetic mice were investigated. The 80 
mg/kg dose of CE-one showed 26.7% decrease of blood glucose compared with control group 
at 30 min which is similar with positive control acarbose (23.3% decrease) in oral maltose 
tolerance test. The 80 mg/kg dose of CE-one showed 39.2% decrease of blood glucose 
compared with control group at 30 min which is similar with positive control acarbose (40.4% 
decrease) in oral starch tolerance test. These results indicated that CE-one can suppress the 
blood glucose level through inhibition of α-glucosidase and α-amylase activity in small intestine 
of normal mice. And 80 mg/kg dose of CE-one can also suppress the blood glucose level in oral 
glucose tolerance test which indicated that it maybe could inhibit the absorption of glucose. The 
results of CE-one in STZ-induced diabetic mice indicated that CE-one can reduce the blood 
glucose level, food intake, water consumption and AST level, improve the liver index, and 
increase the content of hepatic glycogen. CE-one cannot affect the body weight, kidney index, 
ALT level, and insulin level of diabetic mice. The underlying mechanisms maybe because of 
CE-one can improve the condition of liver injury and the content of liver glycogen. In addition, 
CE-one can also decrease total cholesterol level in plasma while has no effect on triglyceride 
level. 
In chapter 6, the stability of CE-one was investigated in vitro and in vivo. The stability of 
CE-one is high below 60˚C and low beyond 100˚C, especially 200˚C. These indicated that 
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banana peel can be dried by oven at 50-60 ˚C for CE-one preparation process. CE-one can be 
used as ingredient for functional food. But it cannot be used for baked food. Furthermore, CE-
one is relatively stable in acidic and neutral conditions. There are still around 75% of CE-one 
remain after kept in SGF and SIF conditions for 4 hours. Moreover, the stability of CE-one is 
also relatively high in vivo. After oral administration of CE-one for 2 h in normal mice, there 
are still around 77% of relative amount remain in the content of stomach and small intestine. 
These results provide some evidence of CE-one for food processing and effectivity in intestine 
as health promoting ingredient. 
The present study first time showed the antihyperglycemic activity and mechanisms and 
stability of CE-one in vitro and in vivo. It not only provides the possibility to use CE-one as 
food ingredient or potential antidiabetic agent, but also provides an alternative way to recycle 
banana peel resource. Nevertheless, further studies about the absorption and metabolism of CE-
one in vivo still need to be investigated in the future.  
iv 
Abbreviation 
DM: diabetes mellitus. 




NMR: nuclear magnetic resonance. 




isoCE-ol: isomer of cycloeucalenol. 
DMSO: dimethyl sulfoxide. 
SGF: simulated gastric fluid. 
SIF: simulated intestinal fluid. 
CMC: carboxymethyl cellulose sodium salt. 
OMTT: oral maltose tolerance test. 
OSTT: oral starch tolerance test. 
OGTT: oral glucose tolerance test. 
STZ: streptozotocin. 
FBG: fasting blood glucose. 
FIN: fasting plasma insulin. 
ALT: alanine transaminase. 
AST: aspartate transaminase. 




Chapter 1 General introduction 
1.1 Banana peel 
Banana including dessert banana and cooking banana, is the second largest produced fruit 
after citrus (approximately 16% of total fruit yield in the world). In 2018, banana production in 
the world was 115.74 million metric tons, with a cultivated area of 5.73 million hectares (El 
Barnossi, et al., 2020). Banana peel which is about 30% - 40% of the total fresh weight is by-
product of banana processing (Albarelli, et al., 2011). Therefore, approximately 34.72 - 46.30 
million metric tons of banana peels are generated in 2018 and this is a potential material for 
further utilization. Currently, most of the banana peel usually used as organic fertilizer or simply 
discarded as waste (Schieber, et al., 2001). This leads to not only the waste of banana peel 
resource but also the pollution of our environment. 
However, banana peel is an important resource. Numerous studies have shown that there 
are many kinds of nutrients and active components in banana peel. Banana peels are full of 
nutrients, such as dietary fiber (40% - 50%), crude protein (8% - 11%), crude fat (2.2% - 10.9%), 
starch (3%), vitamins and high potassium (55.23 - 63.52 mg/kg) (Emaga, et al., 2007). Banana 
peels also contain many active components, such as phenolic compounds, flavonoids, 
phytosterols, carotenoids (Pereira & Maraschin, 2015; Singh, et al., 2016). These active 
components have been reported to exert multiple activities, such as antioxidant (González-
Montelongo, et al., 2010; Rebello, et al., 2014), antibacterial (Rattanavichai & Cheng, 2014), 
antihyperglycemic (Navghare & Dhawale, 2017) and antihypertensive (Qian, et al., 2007; Liu, 
et al., 2009). Some attempts at the practical utilization of banana peels have been made, 
including the production of protein, ethanol, methane, pectin and enzymes (Schieber, et al., 
2001; Clarke, et al., 2008; Emaga, et al., 2008; Essien, et al., 2005; Oberoi, et al., 2011), as 
food for livestock (Onwuka, et al., 1997), and as a bio-sorbent for heavy metals, water 
purification and the removal of phenolic compounds (Anwar, et al., 2010; Albarelli, et al., 2011; 
Annadurai, et al., 2002; Achak, et al., 2009). In order to make full use of banana peel resource, 
we need to find a more promising approach of the integral use of banana peel. 
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1.2 Triterpenes in banana peel 
    Triterpenes, especially tetracyclic and pentacyclic types, represent secondary metabolites 
that are widely distributed in the plant kingdom and found in leaves, stem bark, fruits and roots 
(Jäger, et al., 2009). In banana peel, phytosterols represent majority of the lipophilic extract 
(49%-87.5%) with cycloeucalenone, 31-norcyclolaudenone, stigmasterol, β-sitosterol, and 
campesterol as the major components (Oliveira, et al., 2008; Villaverde, et al., 2013). Many 
studies showed that cycloeucalenone and 31-norcyclolaudenone are identified in many parts of 
banana, such as peel, pulp, flowers, petioles/midrib, leaf sheaths, floral stalk and rachis (Akihisa, 
et al., 1998; Oliveira, et al., 2006). In fact, cycloeucalenone is the main component identified 
in the unripe peel of 10 banana species, with abundances ranging from 806 to 9453 mg/kg of 
dry unripe peels (Villaverde, et al., 2013). Some research indicated that cycloeucalenone 
showed analgesic and anti-inflammatory effects (Lopes, et al., 2014), mild cardiotonic effects 
(Kongkathip, et al., 2002). It can also contribute to hair restoration (Najima, et al., 2016) and 
inhibition of prostate gland enlargement (Akamine, et al., 2009). Moreover, cycloeucalenone 
and 31-norcyclolaudenone have low toxicity (Silva, et al., 2014; Lopes, et al., 2014). These 
studies provide the possibility to make more use of major triterpenes in banana peel. But until 
now, very few studies about the bioactivity of them have been done. 
1.3 The bioactivities of triterpenes in other materials 
Tetracyclic and pentacyclic triterpenes are the two major categories in triterpenes. A large 
number of studies have shown that triterpenes have a wide range of pharmacological effects 
and important biological activities. Numerous reports have revealed many properties of 
triterpenes in vitro and in vivo: such as anti-cancer (Laszczyk, 2009; Li, et al., 2018), antioxidant 
(Ramachandran & Prasad, 2008), anti-inflammatory (Yasukawa, et al., 1996), wound healing 
(Agra, et al., 2015), antidiabetic (Deutschländer, et al., 2011), liver protection (Hu, et al., 2013), 
antiviral (Baltina, et al., 2003) and anti-atherosclerotic (Sudhahar, et al., 2007). 
Many natural triterpenes seem to have promising antidiabetic properties. Some reports 
have shown that triterpenes can exert several antidiabetic mechanisms. They can inhibit 
enzymes involved in carbohydrate metabolism, prevent the development of insulin resistance 
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and normalize plasma glucose and insulin levels (Nazaruk & Borzym-Kluczyk, 2015). Until 
now, no reports have been done about the antihyperglycemic activity of cycloeucalenone, the 
main triterpene in banana peel. But as one of the triterpenes, it maybe has high potential 
possibility of possessing antihyperglycemic effect. 
1.4 Diabetes mellitus 
Diabetes mellitus (DM), which mainly includes type 1 (5% - 10%) and type 2 (90% - 95%), 
is a globally prevalent chronic disease (Neeland & Patel, 2019). According to the reports of 
World Health Organization (2020), approximately 422 million people suffer from DM 
worldwide and 1.6 million deaths are directly attributed to DM annually. After cancer and 
cardiovascular diseases, diabetes has become pandemic to human being due to its high 
prevalence, morbidity, and mortality (Egede & Ellis, 2010). Numerous therapeutic drugs (such 
as insulin, sulfonylureas, metformin, and acarbose) are available for DM with different 
mechanisms of action, including regulation of insulin secretion, glucose absorption, 
carbohydrate metabolism, and antioxidant activity (Samarakoon, et al., 2020). 
However, the current antidiabetic medicines are responsible for various side effects such 
as liver problems, lactic acidosis, diarrhea and high rates of secondary failures (Inzucchi, 2002). 
Therefore, traditional medicinal plants and natural food materials have been necessary 
resources in several countries to control various DM complications, as they are considered as 
less toxicity and side effects compared to synthetic drugs (Balaraman, et al., 2010). 
Many studies have shown that the extracts of some fruits (such as citrus, pomegranate, 
berries, and Prunus species), vegetables (such as onions, peppers, eggplants, bitter melon, and 
brassicas) and mushrooms can inhibit α-amylase and α-glucosidase. The bioactive compounds 
include flavonoids, phenolic acids, tannins, carotenoids, sugars, proteins, vitamin C, fatty acids, 
alkaloids, saponins, and terpenes (Papoutsis, et al., 2021). Among the numerous plants that 
provide medicinal properties, banana is one of the highest produced fruits. Several studies have 
reported that the extracts of different parts of banana plant, such as banana fruits, peels, flowers, 
leaves, stems, and roots, have exerted antidiabetic activities (Shodehinde, et al., 2015; Navghare 
& Dhawale, 2017; Vilhena, et al., 2020; Lakshmi, et al., 2014). Cycloeucalenone, as one of the 
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natural triterpenes with low toxicity, maybe have the potential possibility to be used as an 
antidiabetic agent. The antihyperglycemic activity and mechanisms of major triterpenes in 
banana peel need to be investigated. 
1.5 Research purpose and contents 
By investigating the antihyperglycemic activity and mechanism of major triterpenes in 
banana peel, we will provide the potential possibility of using them as antidiabetic agents. This 
will not only provide the new bioactivity of triterpenes in banana peel, but also provide an 
alternative way to recycle banana peel resource. 
The present research mainly includes five parts: 
Chapter 2 Isolation and purification of major triterpenes from banana peel. 
Chapter 3 Identification of four purified triterpenes by 1D and 2D NMR. 
Chapter 4 Carbohydrate-digesting enzymes inhibitory activities of four purified triterpenes in 
vitro. 
Chapter 5 Antihyperglycemic activity of cycloeucalenone in vivo. 
Chapter 6 Stability of cycloeucalenone in vitro and in vivo.  
5 
Chapter 2 Isolation and purification of major triterpenes from banana 
peel 
2.1 Introduction 
In this chapter, the major triterpenes in banana peel, cycloeucalenone and 31-
norcyclolaudenone will be isolated from banana peel powder. In addition, the similar structure 
compounds, cycloeucalenol and its isomer will also be isolated. Based on the literatures, there 
are some special signals of proton nuclear magnetic resonance (NMR) of cycloeucalenone and 
cycloeucalenol. The special proton NMR signals of cycloeucalenone are shown as below: the 
cyclopropyl protons are represented by two doublets at δ 0.40 and δ 0.60 ppm (Khuong-Huu, 
et al., 1975; Silva, et al., 2014). The special proton NMR signals of cycloeucalenol are shown 
as below: the cyclopropyl protons are represented by two doublets at δ 0.15 and δ 0.38 ppm; a 
proton at C-3 is represented by a multiplet at δ 3.20 ppm (Liu, et al., 2011; Ragasa, et al., 2013). 
If the proton NMR of fraction contains the special proton NMR signals of target compound, it 
means this fraction maybe contain this compound. Otherwise, it doesn't contain. So, the proton 
NMR guided fractionation was used to obtain target compounds. 
2.2 Materials and methods 
2.2.1 Chemicals 
Analytical grade ethyl acetate (EtOAc), hexane (Hex) and methanol (MeOH), and HPLC 
grade MeOH and EtOAc were obtained from Kanto Chemical Co., Inc. (Tokyo, Japan). 
Chloroform-d (CDCl3) was obtained from EMD Millipore Corporation (Darmstadt, Germany). 
Silica gel 60 (0.063–0.200 mm) was obtained from Merck KGaA (Darmstadt, Germany). 
2.2.2 Isolation and purification of triterpenes from banana peel 
Bananas (Musa acuminata) were purchased as a general commercially available from a 
supermarket in Tokyo (Japan). Bananas, yellow-colored ripe products from Ecuador, were 
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washed with tap water, followed by distilled water. The peels were manually removed from the 
pulp and immediately frozen at -20˚C. After freeze-drying, the peels were ground into powder. 
The banana peel powder was sealed and stored at room temperature (25˚C) until further use. 
Banana peel powder was extracted with 100% EtOAc (1 : 10 (w/v)) for 24 h under room 
temperature for 3 times. After filtration, the filtrate was evaporated to nearly dry at 30˚C. The 
banana peel EtOAc extract was obtained after freeze drying. To separate target triterpenes, the 
EtOAc extract was partitioned with Hex and 90% aqueous MeOH (1 : 1 (v/v)) at a ratio of 1 : 
50 (w/v) for 3 times. The Hex layer was collected as mixture containing target triterpenes. 
After concentrated and freeze dried, the Hex layer prepared from banana peel was further 
separated by column chromatography techniques using silica open column and high-
performance liquid chromatography (HPLC) systems (JASCO Corporation, Tokyo, Japan) 
guided by 1H NMR spectra in CDCl3 on a Bruker AV-600 spectrometer (Bruker, Tokyo, Japan). 
The special signals on 1H NMR spectra were used as indicators of target triterpenes as below: 
two doublet signals at δH 0.40 ppm and δH 0.60 ppm derived from a cyclopropane ring (at C-
19) for cycloeucalenone type, and two doublet signals at δH 0.15 ppm and δH 0.38 ppm derived 
from a cyclopropane ring (at C-19) with a multiplet signal at δH 3.20 ppm derived from the 
proton at C-3 for cycloeucalenol type (Khuong-Huu, et al., 1975; Silva, et al., 2014; Liu, et al., 
2011; Ragasa, et al., 2013). The detailed conditions and yield of each fraction were described 
in the results part. 
2.3 Results  
2.3.1 Results of isolation and purification of cycloeucalenone and its isomer 
The hexane layer prepared from banana peel was separated on silica open column (1 : 20, 
w/W) to separate triterpenes. Three fractions (Fr. 1, Fr. 2 and Fr. 3) were collected after eluted 
with EtOAc : Hex at different ratio including 2 : 98, 5 : 95 and 100 : 0 (v/v), using 3 times 
column volume. Then Fr. 2 was further separated by a HPLC system consisted of PU-1586 
pump and UV-2075 detector (JASCO Corporation, Tokyo, Japan), using the ODS-HG-5 (20 × 
250 mm) column with isocratic elution of MeOH : EtOAc = 1 : 1 (v/v) at 5 mL/min monitoring 
at 254 nm with PREP UV cell (range 0.001). After separation, Fr. 2 was divided into 3 fractions, 
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Fr. 2-1: 0 - 16.5 min, Fr. 2-2: 16.5 - 20.5 min and Fr. 2-3: 20.5 - 50 min. Then Fr. 2-2 was further 
isolated using a recycling preparative HPLC system comprised of PU-1586 pump with RCY-
2088 recycling model equipped with UV-2075 detector (JASCO Corporation, Japan). The 
chromatographic separation was performed on ODS-HG-5 (20 × 250 mm) with a flow rate of 
8 mL/min using 100% MeOH by UV detection at 254 nm with TP cell (range 0.0005) to obtain 
two main compounds, compound 1 and 2 (The separation scheme is shown as Fig. 2-1). All 
fractions were checked with proton NMR to get the target fraction. 
Based on the proton NMR of Fr. 1, Fr. 2 and Fr. 3, we found that Fr. 2 (0.95%) contains 
the special signals of cycloeucalenone, two doublet signals at δ 0.42 ppm and δ 0.64 ppm 
derived from a cyclopropane ring, Fr. 2 maybe contain target compounds (Fig. 2-3). After Fr. 2 
was separated by HPLC 1, we collected three fractions (Fr. 2-1, Fr. 2-2 and Fr. 2-3) based on 
the retention time and peaks (Fig. 2-4). After checked with proton NMR, Fr. 2-2 showed contain 
the special signals of cycloeucalenone (Fig. 2-5). Fr. 2-2 was further separated by HPLC with 
recycle mode and collected two fractions, Fr. 2-2-1 and Fr. 2-2-2 (Fig. 2-6). Based on the proton 
NMR, Fr. 2-2-2 (compound 2) maybe cycloeucalenone with recovery rate of 0.52%, Fr. 2-2-1 
(compound 1) maybe its isomer, 31-norcyclolaudenone with recovery rate of 0.17% (Fig. 2-7). 
2.3.2 Results of isolation and purification of cycloeucalenol and its isomer 
The Fr. 3 (0.53%) given from silica column with 100% EtOAc as mentioned above was 
further separated by using silica column again (1 : 20, w/W). Six fractions were collected by 
eluted with EtOAc : Hex at different ratio, namely 0 : 100, 5 : 95, 10 : 90, 15 : 85, 20 : 80 and 
100 : 0 (v/v), using 3 times column volume. The fraction eluted with EtOAc : Hex = 10 : 90 
(v/v) was further separated by HPLC 1 and got 6 fractions based on the retention time and peaks. 
HPLC 1 conditions were as follows: column: ODS-HG-5 (20 × 250 mm); flow rate: 5 mL/min; 
range: 0.001 (PREP cell); wavelength: 254 nm; mobile phase: MeOH : EtOAc = 1 : 1 (v/v). 
The target fraction 1 was further separated by HPLC 2 and got 4 fractions. HPLC 2 conditions 
were as follows: range: 0.0005 (TP cell); flow rate: 8 mL/min; mobile phase: 100% MeOH; 
other parameters are same with HPLC 1. The target fraction 2 was further separated by HPLC 
3 with recycle mode and two main compounds (3 and 4) were obtained (The separation scheme 
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is shown as Fig. 2-2). HPLC 3 conditions are same with HPLC 2. All fractions were checked 
with proton NMR to get the target fraction. 
Based on proton NMR of Fr. 1, Fr. 2 and Fr. 3, we found Fr. 3 contains the special signals 
of cycloeucalenol, two doublet signals at δ 0.16 ppm and δ 0.40 ppm derived from a 
cyclopropane ring, and a multiplet signal at δ 3.24 ppm derived from the proton at C-3, it maybe 
contains cycloeucalenol (Fig. 2-8). Fr. 3 was used for further separation with silica column and 
collected six fractions. After checked with proton NMR of six fractions, we found Fr. 3-3 
contains the special signals of cycloeucalenol, other 5 fractions do not contain cycloeucalenol 
(Fig. 2-9). Fr. 3-3 was further separated by HPLC 1 and collected 6 fractions based on the 
retention time and peaks (Fig. 2-10). After checked with proton NMR, Fr. 3-3-3 was found 
mainly contains cycloeucalenol, Fr. 3-3-4 maybe contains very little amount, and other fractions 
do not contain (Fig. 2-11). Fr. 3-3-3 was further separated by HPLC 2 and collected four 
fractions based on the retention time and peaks (Fig. 2-12). After checked with proton NMR, 
Fr. 3-3-3-2 contains mainly cycloeucalenol, Fr. 3-3-3-3 contains little amount, other fractions 
do not contain (Fig. 2-13). Fr. 3-3-3-2 was further separated with HPLC 3 with recycle mode 
and collected two fractions, Fr. 3-3-3-2-1 and Fr. 3-3-3-2-2 (Fig. 2-14). Based on the proton 
NMR, Fr. 3-3-3-2-2 (compound 4) maybe cycloeucalenol with recovery rate of 0.014%, Fr. 3-
3-3-2-1 (compound 3) maybe its isomer with recovery rate of 0.005% (Fig. 2-15). 
2.4 Discussion 
In banana peel, sterols represent majority of the lipophilic extract (49% - 87.5%) with 
cycloeucalenone, 31-norcyclolaudenone, stigmasterol, β-sitosterol and campesterol as the 
major components whereas in banana pulp lipophilic fraction mainly consists of fatty acids, 
especially unsaturated fatty acids (Oliveira, et al., 2008; Villaverde, et al., 2013). In this chapter, 
four purified compounds were obtained from banana peel. Based on the proton NMR, Fr. 2-2-
1 (compound 1) maybe 31-norcyclolaudenone and its recovery rate is 0.17%. Fr. 2-2-2 
(compound 2) maybe cycloeucalenone and its recovery rate is 0.52%. This is in accordance 
with literatures that cycloeucalenone and 31-norcyclolaudenone are two major components in 
the unripe banana peel (Oliveira, et al., 2008). The content of cycloeucalenone in present study 
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(5200 mg/kg) accorded with the abundances ranging from 806 to 9453 mg/kg of dry unripe 
peels in other study (Villaverde, et al., 2013). Based on our results and literatures, 
cycloeucalenone and 31-norcyclolaudenone are two high content compounds in banana peel. 
More research should be done to fully utilize these two compounds for human beings. 
Based on the proton NMR, Fr. 3-3-3-2-1 (compound 3) maybe the isomer of 
cycloeucalenol and its recovery rate is 0.005%. Fr. 3-3-3-2-2 (compound 4) maybe 
cycloeucalenol and its recovery rate is 0.014%. Compared with the recovery rate of Fr. 2-2-1 
and Fr. 2-2-2, Fr. 3-3-3-2-1 and Fr. 3-3-3-2-1 showed lower recovery rate, this indicated that 
the content of them in banana peel is very low. Our results indicated that Fr. 3-3-3-2-1 and Fr. 
3-3-3-2-1 have higher polarity than Fr. 2-2-1 and Fr. 2-2-2 and they are more difficult to get the 
pure compounds. In order to get pure compounds, all these four compounds need to use the 
recycle mode of HPLC to separate from their isomers. Cycloeucalenol had been identified in 
different part of banana and the content usually is very low (Oliveira, et al., 2006). This is the 
first time to isolate the pure isomer of cycloeucalenol from banana peel. In addition, 
cycloeucalenol and its isomer, with low toxicity, were also found in the plant Boophone disticha 
(Adewusi, et al., 2013). 
2.5 Conclusion 
Four purified compounds were obtained from banana peel EtOAc extract. Fr. 2-2-1 
(compound 1) with 0.17% recovery rate maybe 31-norcyclolaudenone. Fr. 2-2-2 (compound 2) 
with 0.52% recovery rate maybe cycloeucalenone. Fr. 3-3-3-2-1 (compound 3) with 0.005% 
recovery rate maybe the isomer cycloeucalenol. Fr. 3-3-3-2-2 (compound 4) with 0.014% 
recovery rate maybe cycloeucalenol. The structures of these four purified compounds need to 
be analyzed and confirmed with 1D and 2D NMR in the next chapter. 
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Fig. 2-1 Separation scheme of cycloeucalenone and its isomer from banana peel. 
Note: w: weight of sample (g), v: volume of solvent (mL), W: weight of silica gel (g). Values 
in parenthesis are recovery rate from banana peel powder. 
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Fr. 1 (2.82%) Fr. 2 (0.95%) Fr. 3 (0.53%) 
Fr. 2-1 (0.04%) Fr. 2-2 (0.76%) Fr. 2-3 (0.06%) 
Fr. 2-2-1 (0.17%) 
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Fr. 2-2-2 (0.52%) 
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HPLC 2 (ODS column, 20 ◊ 250 mm, 100% 
MeOH; 8 mL/min; 254 nm; recycle mode) 
HPLC 1 (ODS column, 20◊250 mm, MeOH : 
EtOAc = 1 : 1; 5 mL/min; 254 nm) 
100% EtOAc (w : v = 1 : 10, 24 h / time 























Fig. 2-2 Separation scheme of cycloeucalenol and its isomer from banana peel. 
Note: w: weight of sample (g), W: weight of silica gel (g). Values in parenthesis are recovery 
rate from banana peel powder. 
  
Fr. 3 (0.53%) 
EtOAc : Hex = 
5 : 95 
EtOAc : Hex = 
10 : 90 
EtOAc : Hex = 
15 : 85 
EtOAc : Hex = 
20 : 80 
100% EtOAc 100% Hex 
Silica column (w : W = 1 : 20) 
Fr. 3-1 (0.005%) Fr. 3-2 (0.033%) Fr. 3-3 (0.143%) Fr. 3-4 (0.197%) Fr. 3-5 (0.026%) Fr. 3-6 (0.076%) 
Fr. 3-3-1  Fr. 3-3-2  Fr. 3-3-4  Fr. 3-3-5  Fr. 3-3-6  Fr. 3-3-3 (0.058%) 
Fr. 3-3-3-1  Fr. 3-3-3-4  Fr. 3-3-3-3  Fr. 3-3-3-2 (0.023%) 
Fr. 3-3-3-2-1 (0.005%) 
Compound 3 
Fr. 3-3-3-2-2 (0.014%) 
Compound 4 
HPLC 1 (ODS column, 20 ◊ 250 mm, 
MeOH : EtOAc = 1 : 1; 5 mL/min; 254 nm) 
HPLC 2 (ODS column, 20◊250 mm, 
100% MeOH; 8 mL/min; 254 nm) 
HPLC 3 (ODS column, 20 ◊ 250 mm, 100% 
MeOH; 8 mL/min; 254 nm; recycle mode) 
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Fig. 2-3 The proton NMR spectra of Fr. 1, Fr. 2 and Fr. 3. 
 
Fig. 2-4 HPLC chromatogram of Fr. 2. 
 











Fig. 2-6 HPLC chromatogram (recycle mode) of Fr. 2-2 
 
 
Fig. 2-7 The proton NMR spectra of Fr. 2-2-1 and Fr. 2-2-2.  











Fig. 2-8 The proton NMR spectra of Fr. 1 and Fr. 3. 
 













Fig. 2-10 HPLC chromatogram of Fr. 3-3 
 
















Fig. 2-12 HPLC chromatogram of Fr. 3-3-3. 
 
 













Fig. 2-14 HPLC chromatogram (recycle mode) of Fr. 3-3-3-2. 
 
 
Fig. 2-15 The proton NMR spectra of Fr. 3-3-3-2-1 and Fr. 3-3-3-2-2. 











Chapter 3 Identification of four purified triterpenes by 1D and 2D NMR 
3.1 Introduction 
In last chapter, four purified compounds were obtained from banana peel EtOAc extract. 
In order to confirm the structures of these four compounds, 1D and 2D NMR of them were 
analyzed and identified. The results were also compared with literatures. 
3.2 Materials and methods 
The NMR spectra of four purified compounds were recorded on a Bruker AVANCE III 
600 MHz with 1H (600 MHz) and 13C (150 MHz) in CDCl3 (
1H: δ 7.29 ppm and 13C: δ 77.03 
ppm) along with COSY, HMQC, HMBC, DEPT 90 and DEPT 135 to characterize these 
compounds. And the results were also compared with literature data. 
3.3 Results 
The specific 1H NMR spectrum of compound 1 showed a broad singlet signal at δ 4.69 
ppm (2H) characteristic of a terminal double bond. Two doublet signals at δ 0.42 ppm (1H, J = 
4.02 Hz) and δ 0.64 ppm (1H, J = 3.78 Hz) corresponds to a cyclopropane ring present in 
cycloartane-type triterpene. The 13C NMR spectrum showed 30 carbon signals including a 
double bond between C-25 and C-27 (Δ25(27)) and a carbonyl group at C-3. These data of 
compound 1 corresponded to the data of 31-norcyclolaudenone C30H48O (syn: 
cyclomusalenone) in the previous reports (Ragasa, et al., 2007; Silva, et al., 2014). As this 
triterpene possessing Δ25(27) double bond is an isomer of cycloeucalenone (CE-one) which 
possessing Δ24(28) double bond, we describe 31-norcyclolaudenone as isomer of CE-one 
(isoCE-one) in the current report. 
The specific 1H NMR spectrum of compound 2 showed two broad singlet signals at δ 4.69 
ppm (1H) and δ 4.74 ppm (1H) characteristic of a terminal double bond. Two doublet signals 
at δ 0.42 ppm (1H, J = 4.02 Hz) and δ 0.64 ppm (1H, J = 3.84 Hz) corresponds to a cyclopropane 
ring present in cycloartane-type triterpene. The 13C NMR spectrum showed 30 carbon signals 
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including a double bond between C-24 and C-28 (Δ24(28)) and a carbonyl group at C-3. These 
data of compound 2 corresponded to the data of cycloeucalenone C30H48O (CE-one) in the 
previous reports (Khuong-Huu, et al., 1975; Silva, et al., 2014). 
The specific 1H NMR spectrum of compound 3 showed a broad singlet signal at δ 4.69 
ppm (2H) characteristic of a terminal double bond. Two doublet signals at δ 0.16 ppm (1H, J = 
4.02 Hz) and δ 0.40 ppm (1H, J = 3.72 Hz) corresponds to a cyclopropane ring present in 
cycloartane-type triterpene. And a multiplet signal at δ 3.24 ppm corresponds to the proton at 
C-3. The 13C NMR spectrum showed 30 carbon signals including a double bond between C-25 
and C-27 and a hydroxyl group at C-3. These data are in agreement with previous reports 
(Akihisa, et al., 1998; Adewusi, 2012) characterize compound 3 as positional-isomer of 
cycloeucalenol C30H50O. As this triterpene possessing Δ25(27) double bond is an isomer of 
cycloeucalenol (CE-ol) which possessing Δ24(28) double bond, we describe it as isomer of CE-
ol (isoCE-ol) in the current report. 
The specific 1H NMR spectrum of compound 4 showed two broad singlet signals at δ 4.69 
ppm (1H) and δ 4.74 ppm (1H) characteristic of a terminal double bond. Two doublet signals 
at δ 0.16 ppm (1H, J = 4.02 Hz) and δ 0.40 ppm (1H, J = 3.78 Hz) corresponds to a cyclopropane 
ring present in cycloartane-type triterpene. And a multiplet signal at δ 3.24 ppm corresponds to 
the proton at C-3. The 13C NMR spectrum showed 30 carbon signals including a double bond 
between C-24 and C-28 and a hydroxyl group at C-3. These data are in agreement with previous 
reports (Liu, et al., 2011; Ragasa, et al., 2013) characterize compound 4 as cycloeucalenol 
C30H50O (CE-ol). 
The 1H and 13C NMR data of four purified triterpenes were shown in Table 3-1 and Table 
3-2. The spectra of 1D and 2D NMR of four compounds were shown in Appendix. After 
analyzed with 1H and 13C along with COSY, HMQC, HMBC, DEPT 90, DEPT 135 and 
compared with literature data, the chemical structures of four compounds were obtained and 
shown in Fig. 3-1. The structural differences of them are the carbonyl group or hydroxy group 
at C-3 and the position of double bond (Δ25(27) or Δ24(28)) in the side chain. 
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3.4 Discussion 
CE-one and isoCE-one are two isomeric ketones previously identified in different parts of 
banana plant (Oliveira, et al., 2006). These two compounds have been detected in the unripe 
peel of banana fruit ‘Dwarf Cavendish’ as the major triterpenes (Oliveira, et al., 2008). And 
CE-one is the main component identified in the lipophilic extractives of unripe peel of ten Musa 
species, with an abundance ranging from 806 to 9453 mg/kg of dry unripe peels (Villaverde, et 
al., 2013). The major triterpene, CE-one had shown mild cardiotonic effects (Kongkathip, et 
al., 2002), hair restoration effects (Najima, et al., 2016), analgesic and anti-inflammatory effects 
(Lopes, et al., 2014). Antimicrobial tests of isoCE-one indicated that it has weak activity against 
C. albicans; E. coli, P. aeruginosa, and T.mentagrophytes; and is inactive against B. subtilis, S. 
aureus, and A. niger (Ragasa, et al., 2007). More importantly, CE-one and isoCE-one have low 
cytotoxicity (Silva, et al., 2014). 
CE-ol and isoCE-ol were also identified in traditional medicine plant Boophone disticha. 
A dose-dependent decrease in cell viability of the mixture compound of two positional-isomers 
was observed using both MTT and neutral red assays. The IC50 values of MTT and neutral red 
assays were 173.0 ± 5.1 μM and 223.0 ± 6.4 μM, respectively, indicating that the low toxicity 
of the compound (Adewusi, et al., 2013). Some other studies also indicated that CE-ol may 
have potential anti-inflammatory, antihyperglycemic and cardiotonic effects (Akihisa, et al., 
2000; Ragasa, et al., 2013; Kongkathip, et al., 2002). 
3.5 Conclusion 
Based on the data of 1D and 2D NMR and the literatures, compound 1 is 31-
norcyclolaudenone (isoCE-one), compound 2 is cycloeucalenone (CE-one), compound 3 is 
isomer of cycloeucalenol (isoCE-ol), compound 4 is cycloeucalenol (CE-ol). These four 
compounds are similar compounds. The structural differences of them are the carbonyl group 
or hydroxy group at C-3 and the position of double bond in the side chain. 
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Fig. 3-1 Chemical structures of four triterpenes in banana peel extract. 
Note: 31-norcyclolaudenone (isoCE-one, 1), cycloeucalenone (CE-one, 2), isomer of 




Table 3-1 1H NMR of isoCE-one, CE-one, isoCE-ol and CE-ol 
Position 
δH ppm 
isoCE-one CE-one isoCE-ol CE-ol 
C-1 1.61, 1.89 1.59, 1.90 1.30, 1.57 1.30, 1.57 
C-2 2.45 (2H) 2.45 (2H) 1.43, 2.01 1.44, 2.01 
C-3 - - 3.24 3.24 
C-4 2.26 2.26 1.19 1.20 
C-5 1.60 1.60 1.20 1.23 
C-6 0.76, 1.72 0.77, 1.73 0.60, 1.70 0.61, 1.70 
C-7 1.12, 1.38 1.14, 1.38 1.30, 1.90 1.32, 1.95 
C-8 1.66 1.67 1.60 1.60 
C-9 - - - - 
C-10 - - - - 
C-11 1.27, 2.06 1.28, 2.06 1.07, 1.33 1.09, 1.33 
C-12 1.68 (2H) 1.69 (2H) 1.63 (2H) 1.65 (2H) 
C-13 - - - - 
C-14 - - - - 
C-15 1.32 (2H) 1.34 (2H) 1.30 (2H) 1.32 (2H) 
C-16 1.32, 1.93 1.34, 1.97 1.22, 2.00 1.23, 2.01 
C-17 1.61 1.65 1.59 1.62 
C-18 1.02 (3H) 1.03 (3H) 0.98 (3H) 0.99 (3H) 
C-19 0.42, 0.64 0.42, 0.64 0.16, 0.40 0.17, 0.41 
C-20 1.32 1.44 1.30 1.42 
C-21 0.89 (3H) 0.93 (3H) 0.88 (3H) 0.92 (3H) 
C-22 0.95, 1.36 1.19, 1.60 0.95, 1.36 1.17, 1.60 
C-23 1.19, 1.48 1.92, 2.15 1.18, 1.45 1.91, 2.15 
C-24 2.13 - 2.12 - 
C-25 - 2.26 - 2.26 
C-26 1.66 (3H) 1.05 (3H) 1.66 (3H) 1.05 (3H) 
C-27 4.69 (2H) 1.06 (3H) 4.69 (2H) 1.06 (3H) 
C-28 1.03 (3H) 4.69, 4.74 1.02 (3H) 4.69, 4.74 
C-29 1.01 (3H) 1.01 (3H) 1.00 (3H) 1.01 (3H) 
C-30 0.92 (3H) 0.94 (3H) 0.90 (3H) 0.92 (3H) 























C-1 32.8 32.8 32.8 32.8 30.8 31.0 30.8 30.8 
C-2 41.0 41.0 41.0 40.8 34.8 35.0 34.8 34.8 
C-3 213.5 213.3 213.5 212.2 76.6 76.8 76.6 76.6 
C-4 50.0 50.0 50.0 49.8 44.6 44.8 44.6 44.6 
C-5 46.1 46.1 46.1 45.9 43.3 43.6 43.3 43.3 
C-6 25.9 25.9 25.9 25.8 24.7 24.9 24.7 24.7 
C-7 25.2 25.2 25.2 25.1 28.1 28.3 28.1 28.1 
C-8 47.1 47.1 47.1 46.9 46.9 47.1 46.9 46.9 
C-9 25.0 25.0 25.0 24.9 23.6 23.8 23.5 23.5 
C-10 29.3 29.7 29.3 29.3 29.5 29.8 29.5 29.5 
C-11 27.2 27.2 27.2 26.9 25.2 25.4 25.2 25.2 
C-12 32.9 32.9 32.9 32.8 35.4 35.6 35.4 35.3 
C-13 45.4 45.3 45.4 45.2 45.3 45.6 45.3 45.3 
C-14 48.8 48.8 48.8 48.7 48.9 49.1 48.9 48.9 
C-15 35.5 35.6 35.4 35.3 32.9 33.1 32.9 32.9 
C-16 28.1 28.0 28.1 28.0 27.0 27.2 27.0 27.0 
C-17 52.2 52.2 52.2 52.1 52.2 52.4 52.2 52.2 
C-18 18.0 17.9 18.0 17.9 17.8 18.0 17.8 17.8 
C-19 27.0 26.9 27.0 27.1 27.3 27.5 27.3 27.2 
C-20 36.1 36.0 36.1 36.0 36.1 36.4 36.1 36.1 
C-21 18.4 18.3 18.3 18.3 18.4 18.6 18.3 18.3 
C-22 33.9 33.9 34.9 35.0 34.0 34.0 35.0 35.0 
C-23 31.5 31.5 31.3 31.3 31.5 31.7 31.3 31.3 
C-24 41.7 41.6 156.9 156.1 41.7 41.8 156.9 156.9 
C-25 150.5 150.2 33.8 33.7 150.5 150.5 33.8 33.8 
C-26 18.7 18.6 22.0 21.8 18.6 18.9 22.0 22.0 
C-27 109.5 109.4 21.9 21.8 109.4 109.6 21.9 21.9 
C-28 20.2 20.2 106.0 105.6 20.2 20.1 105.9 105.9 
C-29 10.8 10.7 10.8 10.7 14.4 14.6 14.4 14.4 
C-30 19.2 19.2 19.2 19.1 19.1 19.4 19.1 19.1 
Note: The reference data of four compounds were from literatures (a: Ragasa, et al., 2007; b: 
Khuonghuu, et al., 1975; c: Adewusi, 2012; d: Liu, et al., 2011). 
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Chapter 4 Carbohydrate-digesting enzymes inhibitory activities of four 
purified triterpenes in vitro 
4.1 Introduction 
Controlling plasma glucose level is essential to delay or prevent DM. One possible way to 
decrease the blood sugar absorption rate from the small intestine is to slow or interrupt the 
digestion of carbohydrate, the major dietary source of glucose (Josse, et al., 2003). The 
inhibition of enzymes that digest carbohydrate, such as α-glucosidase and α-amylase have been 
studied as a method to control blood sugar levels (Ali, et al., 2006; Svensson, et al., 2004).  
α-Glucosidase is a membrane-bound enzyme located at the epithelium of the small 
intestine, which catalyzes the cleavage of glucose from disaccharides and oligosaccharides 
(Hamid, et al., 2015). α-Amylase catalyzes the hydrolysis of α - (1, 4) - glycosidic linkages to 
produce maltose and glucose, whereas α-glucosidase releases glucose from maltose and/or 
sucrose (Sogaard-Andersen & Valentin-Hansen, 1993; Teeri, 1991). So, absorption of glucose 
into the bloodstream can be delayed by inhibiting these enzymes, and then ameliorating DM 
symptoms such as hyperglycemia.  
The final concentration of sample required to inhibit 50% of the α-glucosidase and α-
amylase activity under the specified condition was described as IC50. The IC50 value of four 
triterpenes were measured and compared. Then the structure-activity relationships of four 
triterpenes were investigated. In addition, the kinetic analysis of CE-one in α-glucosidase 
inhibitory assay had been elucidated. 
4.2 Materials and methods 
4.2.1 Chemicals 
Acarbose hydrate (>98.0%) was purchased from Tokyo Chemical Industry Co., Ltd. 
(Tokyo, Japan). Soluble starch was purchased from Fujifilm Wako Pure Chemical Corporation 
(Osaka, Japan). p-Nitrophenyl-α-D-glucopyranose (p-NPG), α-glucosidase from yeast, and α-
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amylase from porcine pancreas were purchased from Sigma-Aldrich (Darmstadt, Germany).  
4.2.2 Inhibitory assay against α-glucosidase 
The α-glucosidase inhibition assay was conducted according to previous report (Asghari, 
et al., 2015) with slight modifications. Potassium phosphate buffer (100 mM, pH 7.0) (50 μL) 
and samples (10 μL) with varying concentrations (four purified compounds: 0, 40, 80, 120, 160, 
200, 240, 300 μg/mL; acarbose: 0, 400, 800, 1200, 1600, 2000, 2400, 3000 μg/mL) dissolved 
in 50% MeOH were mixed prior to the addition of 20 μL of yeast α-glucosidase (0.1 U/mL) 
(As). The sample replaced by 50% MeOH was used as control (Ac). The enzyme replaced by 
potassium phosphate buffer (100 mM, pH 7.0) was used as blank of samples (Bs) or blank of 
control (Bc). The mixture was pre-incubated at 37˚C for 15 min. Addition of 20 μL (1.0 mM) 
p-NPG, as the substrate marked the initiation of the reaction. The reaction was carried out with 
further incubation at 37˚C for 15 min and terminated by adding 50 μL of sodium carbonate (200 
mM). Enzyme activity was determined by measuring the absorbance at 405 nm of the p-
nitrophenol liberated from p-NPG with a microplate reader (Thermomax; Molecular Devices, 
Sunnyvale, USA). Acarbose was used as positive control. The α-glucosidase inhibitory activity 
was calculated using the following formula: Inhibitory rate (%) =100 × [(Ac-Bc)-(As-Bs)] / 
(Ac-Bc).  
4.2.3 Inhibitory assay against α-amylase 
The α-amylase inhibition assay was conducted using the previous method (Xiao, et al., 
2006) with modifications. After 30 μL of sodium phosphate buffer (20 mM, pH 6.9) and 10 μL 
of diverse concentrations (four purified compounds: 0, 40, 80, 120, 160, 200, 240, 300 μg/mL; 
acarbose: 0, 10, 30, 50, 70, 100, 150 μg/mL) of test samples dissolved in 50% aqueous MeOH 
were mixed (As) and the 50% MeOH used as control (Ac), 30 μL of 0.1 U/mL α-amylase 
dissolved in sodium phosphate buffer was added and incubated at 37˚C for 10 min. The enzyme 
replaced by sodium phosphate buffer was used as blank of sample (Bs) or blank of control (Bc). 
Then, 30 μL of 0.5 mg/mL starch solution dissolved in sodium phosphate buffer was added and 
incubated at 37˚C for 10 min. The reaction was stopped by adding 50 μL of 5 mM iodine 
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contained 1 mM HCl solution. The absorbance was measured at 590 nm to detect remaining 
starch by a microplate reader (Thermomax; Molecular Devices, Sunnyvale, USA). Acarbose 
was used as positive control. The α-amylase inhibitory activity was calculated using the 
following formula: Inhibitory rate (%) =100 × [(Bc-Ac)-(Bs-As)] / (Bc-Ac). 
4.2.4 Kinetic analysis of CE-one in α-glucosidase inhibitory assay 
To describe the inhibition type of CE-one in α-glucosidase inhibitory assay, the 
Lineweaver-Burk equation in double reciprocal form was expressed as followed equations (1) 


















]                  (1) 







                              (2) 
Where v is the enzyme reaction rate in the absence and presence of sample. Ki and Km are 
the inhibition constant and Michaelis-Menten constant, respectively. α is the ratio of the 
uncompetitive inhibition constant to competitive inhibition constant. [I] and [S] are the 
concentrations of inhibitor and substrate, respectively.  
However, these equations are only valid for the linear relationship, Ki cannot be determined 
directly from the usual equations when the parabolic relationship between slope and [I]. Thus, 











)                    (3) 
Where the ln(slope) is plotted versus the corresponding inhibitor. The plot has a slope of 
(Km/Vmax) × 1/Ki when the plot is produced linearly. The value of Ki can be obtained from the 
above equation.  
All data are expressed as mean ± standard deviation (M ± SD, n = 3). The data were 
analyzed by independent-samples Student’s t-test with SPSS 22.0 software (IBM Corporation, 
New York, USA). 
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4.3 Results 
4.3.1 α-Glucosidase inhibitory activity of four triterpenes 
It was found that CE-one and isoCE-one inhibited α-glucosidase activity in a 
concentration-dependent manner. With the increasing concentration of acarbose, CE-one and 
isoCE-one, α-glucosidase inhibitory activity increased remarkably (Fig. 4-1A, 4-1B and 4-1C). 
In contrast, the results of both CE-ol and isoCE-ol showed no concentration-dependent manner 
in α-glucosidase inhibitory activity (Fig. 4-1D and 4-1E). The IC50 values of acarbose, CE-one 
and isoCE-one were estimated to be 295.43 ± 4.13 μM, 31.83 ± 2.46 μM, and 38.85 ± 1.54 μM, 
respectively (Table 4-1). CE-ol and isoCE-ol cannot get the IC50 value under the concentration 
from 4 to 30 μg/mL (below 10%). The IC50 value of CE-ol has been reported to be more than 
1000 μM while the acarbose is 884.6 μM in α-glucosidase inhibitory assay (Srisurichan & 
Pornpakakul, 2015). Compared with acarbose, IC50 values of CE-one and isoCE-one showed 
significant difference in α-glucosidase inhibitory activity (p < 0.05) (Table 4-1). CE-one and 
isoCE-one exhibited higher inhibitory activity than acarbose. Compared with isoCE-one, IC50 
value of CE-one showed the significant difference (p < 0.05) (Table 4-1). CE-one exhibited 
higher inhibitory activity than isoCE-one in α-glucosidase. 
4.3.2 α-Amylase inhibitory activity of four triterpenes 
It was also found that CE-one and isoCE-one inhibited α-amylase activity in a 
concentration-dependent manner. With the increasing concentration of acarbose, CE-one and 
isoCE-one, α-amylase inhibitory activity increased prominently (Fig. 4-2A, 4-2B and 4-2C). 
On the contrary, the results of both CE-ol and isoCE-ol also showed no concentration-dependent 
manner in α-amylase inhibitory activity (Fig. 4-2D and 4-2E). The IC50 values of acarbose, CE-
one and isoCE-one were estimated to be 10.27 ± 1.16 μM, 20.33 ± 0.59 μM and 27.63 ± 0.83 
μM, respectively (Table 4-2). CE-ol and isoCE-ol cannot get the IC50 value under the 
concentration from 4 to 30 μg/mL (below 10%). Compared with acarbose, IC50 values of CE-
one and isoCE-one showed significant difference in α-amylase inhibitory activity (p < 0.05) 
(Table 4-2). CE-one and isoCE-one showed lower inhibitory activity than acarbose. Compared 
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with isoCE-one, IC50 value of CE-one also showed significant difference (p < 0.05) (Table 4-
2). CE-one exhibited higher inhibitory activity than isoCE-one in α-amylase. 
4.3.3 Results of kinetic analysis of CE-one in α-glucosidase inhibitory assay 
Lineweaver-Burk plots of CE-one in the α-glucosidase inhibitory activity were constructed, 
as displayed in Fig. 4-3. The apparent Vmax and Km both appeared to change concurrently by 
various concentrations of CE-one indicating that CE-one induced mixed-type inhibition of α-
glucosidase (Fig. 4-3A). The secondary plot of slope versus concentration of the inhibitor [CE-
one] got a parabolic curve (Fig. 4-3B) indicating that CE-one induced a parabolic mixed-type 
inhibition. By using equation (2), the Ki value was calculated as 73.86 μM (Fig. 4-3C).  
4.4 Discussion 
Based on the structure and activity of these four triterpenes, our results indicated that the 
carbonyl ketone at C-3 is crucial for their α-glucosidase and α-amylase inhibitory activities. 
And the position of double bond in the side chain can also affect these inhibitory activities. 
There are several reports on plant-derived triterpenes inhibitory activity against 
carbohydrate digestive enzymes (Nazaruk & Borzym-Kluczyk, 2015). Regarding lupane-type 
triterpenes in other studies, α-glucosidase and α-amylase inhibitory activities of lupenone, 
which possesses a carbonyl ketone at C-3 (IC50: 88.62 μM and 108.61 μM, respectively) were 
stronger than those of lupeol, which possesses a hydroxy group at C-3 (IC50: 90.86 μM and 
116.19 μM, respectively), with acarbose IC50 values of 44.88 μM and 42.67 μM, respectively 
(Ochieng, et al., 2020). Our results agree with those of other studies, showing that the carbonyl 
ketone at C-3 is important for α-glucosidase and α-amylase inhibitory activities (Pujirahayu, et 
al., 2019; Yonemoto, et al., 2014). More interestingly, based on the comparison of IC50 values, 
lupenone has a marginally stronger (less than two times) α-glucosidase inhibitory activity than 
lupeol, while CE-one showed a significantly stronger inhibitory activity (more than 10 times) 
than CE-ol. It has been reported that lupenone in banana peel is a candidate possessing potent 
antidiabetic activity in alloxan-induced diabetic mice (Wu, et al., 2015). However, our 
bioassay-guided fractionation did not identify lupenone in banana peel extract as an inhibitor 
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of α-glucosidase and α-amylase. Our results provide no information on the content of lupenone 
in our material, however, CE-one and isoCE-one are the major inhibitors in banana peel based 
on these results.  
In addition, our results revealed the contribution of double bond in the side chain (C21-
C28) of the triterpenes to their inhibitory properties. CE-one Δ24(28) exhibited higher 
inhibitory activities against both α-glucosidase and α-amylase than isoCE-one Δ25(27). Our 
results are consistent with those of cycloartane-type triterpene acids, in which the position of 
the double bond in the side chain is also important for α-glucosidase inhibitory activity 
(Pujirahayu, et al., 2019). The effects of the double bond position were not elucidated in this 
study. However, the proton NMR data of the two purified triterpenes showed different signal 
patterns for paired geminal protons on each double bond. Regarding the double bond of CE-
one, two separated signals at δ 4.69 ppm (1H) and δ 4.74 ppm (1H) were identified. However, 
one overlapped signal at δ 4.69 ppm (2H) were identified from isoCE-one. If the overlapped 
signals of isoCE-one are derived from two exchangeable protons on the terminal double bond 
in the chemical environment, the conformation of the side chain will be more flexible. These 
data suggest that moderately restricted flexibility of the side chain is effective in enhancing 
triterpene inhibitory activity against carbohydrate digestive enzymes. Further experiments, with 
three-dimensional analysis, are required to elucidate the role of terminal double bond in the 
triterpene inhibition mechanism against carbohydrate digestive enzymes. 
In the previous reports on α-glucosidase inhibitors, several triterpene acids, such as ursolic 
acid, corosolic acid and oleanolic acid, are known to show uncompetitive or non-competitive 
modes of inhibition (Salah, et al., 2014; Hou, et al., 2009; Zhang, et al., 2017). The inhibition 
mode of lupenol against α-glucosidase is non-competitive (Ramu, et al., 2014), and that of 
lupenone against α-amylase is a mixed type (Yonemoto, et al., 2014). Our results using CE-one 
possessing a carbonyl ketone at C-3 demonstrated mixed-type inhibition against α-glucosidase. 
This suggests that the C-3 ketonic triterpenes have more complex properties than triterpene 
acids in carbohydrate digestive enzyme inhibition.  
To the best of our knowledge, the present study is the first report about the inhibitory 
activity of and active sites for CE-one on α-glucosidase and α-amylase. This study indicates a 
potential application of banana peel-derived triterpenes as antidiabetic agents. 
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4.5 Conclusion 
CE-one showed higher α-glucosidase and α-amylase inhibitory activities than that of 
isoCE-one. In contrast, CE-ol and isoCE-ol had insufficient inhibitory activity against either 
enzyme. The IC50 values of CE-one and isoCE-one on α-glucosidase were 31.83 ± 2.46 μM and 
38.85 ± 1.54 μM, respectively. And their IC50 values on α-amylase were 20.33 ± 0.59 μM and 
27.63 ± 0.83 μM, respectively. The main active sites of CE-one and isoCE-one are the carbonyl 
group at C-3 and double bond in the side chain. CE-one induced a parabolic mixed-type 
inhibition with the Ki value of 73.86 μM in α-glucosidase inhibitory assay.  
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Fig. 4-3 Kinetic analysis of α-glucosidase inhibition by CE-one. 
Lineweaver-Burk plots for α-glucosidase (0.1 U/mL) with various concentrations of CE-one 
with 4.71 (▂), 9.42 (◆), 11.77 (▲), 23.55 (●), and 37.67 (■) μM (Panel A). The secondary plot 
of slope versus [CE-one] (Panel B). The secondary plot of parabolic type of inhibition applied 

















































Table 4-1 The IC50 of four compounds in α-glucosidase inhibition assay. 
Compound α-glucosidase (μM) 
cycloeucalenone (CE-one) 31.83±2.46**, ## 
31-norcyclolaudenone (isoCE-one) 38.85±1.54** 
cycloeucalenol (CE-ol) - 
isomer of cycloeucalenol (isoCE-ol) - 
acarbose 295.43±4.13 
Note: All data are expressed as mean ± standard deviation (M ± SD, n = 3). The symbol “-” 
represents cannot estimate IC50. The symbol “*” represents the difference between samples 
(CE-one and isoCE-one) and positive control (acarbose) (*: p < 0.05; **: p < 0.01). The symbol 
“#” represents the difference between CE-one and isoCE-one (#: p < 0.05; ##: p < 0.01).  
 
Table 4-2 The IC50 of four compounds in α-amylase inhibition assay. 
Compound α-amylase (μM) 
cycloeucalenone (CE-one) 20.33±0.59**, ## 
31-norcyclolaudenone (isoCE-one) 27.63±0.83** 
cycloeucalenol (CE-ol) - 
isomer of cycloeucalenol (isoCE-ol) - 
acarbose 10.27±1.16 
Note: All data are expressed as mean ± standard deviation (M ± SD, n = 3). The symbol “-” 
represents cannot estimate IC50. The symbol “*” represents the difference between samples 
(CE-one and isoCE-one) and positive control (acarbose) (*: p < 0.05; **: p < 0.01). The symbol 




Chapter 5 Antihyperglycemic activity of cycloeucalenone in vivo 
5.1 Introduction 
In the previous chapter, CE-one had shown the highest α-glucosidase and α-amylase 
inhibitory activities in vitro. But the effect of CE-one in vivo still unclear. In this chapter, the 
carbohydrate-loading tests of CE-one in normal mice and the antihyperglycemic activity of CE-
one in STZ-induced diabetic mice were investigated. 
5.2 Materials and methods 
5.2.1 Chemicals 
Maltose monohydrate, D (+)-glucose and DMSO were obtained from Kanto Chemical Co., 
Inc. (Tokyo, Japan). Acarbose hydrate was purchased from Tokyo Chemical Industry Co., Ltd. 
(Tokyo, Japan). Soluble starch, streptozotocin (STZ) and carboxymethyl cellulose sodium salt 
(CMC) were bought from Fujifilm Wako Pure Chemical Corporation (Osaka, Japan). 
Metformin was bought from Sanwa Kagaku Kenkyusho Co., Ltd. (Nagoya, Japan). 
5.2.2 Animals 
The male ddY mice (6 weeks old) and male ICR mice (7 weeks old) were purchased from 
SLC, Inc. (Hamamatsu, Japan). They were raised at 24 ± 1˚C, 50 ± 10% humidity and a 12 h 
light-dark cycle condition (lights on from 8:00 A.M. to 8:00 P.M.). The mice had free access to 
water and standard food and acclimated for one week. The animal experiments were done 
according to the guidelines for animal experiment of Tokyo University of Marine Science and 
Technology with the approval of the animal care and use committee of Tokyo University of 
Marine Science and Technology. 
5.2.3 Carbohydrate-loading tests of CE-one in normal mice 
5.2.3.1 Oral maltose and starch tolerance tests in normal mice 
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After fasting for 20 h, three groups (n = 5) of ddY mice were given different dose of CE-
one (20, 40, and 80 mg/kg body weight) by oral administration, 30 min later, maltose or starch 
(2 g/kg body weight) was given to mice with the same method. Before given CE-one, collect 
blood from tail as 0 min, after given maltose or starch collect blood in small tubes with heparin 
sodium at 30, 60, 90, and 120 min, respectively. One present of CMC was used for control 
group (n = 5). Acarbose (40 mg/kg body weight) was used for positive control group (n = 5). 
After blood was centrifuged at 8000 rpm for 3 min (Centrifuge MCD-2000, AS ONE, Japan), 
the plasma was obtained. The blood glucose level was measured by commercial assay kit 
(Fujifilm Wako Pure Chemical Corporation, Osaka, Japan) with a microplate reader 
(Thermomax; Molecular Devices, Sunnyvale, USA). The area-under-the-concentration-curve 
(AUC) as difference from initial value of each group was calculated with the trapezoidal rule. 
And the AUC value (% of control) was obtained. 
5.2.3.2 Oral glucose tolerance test in normal mice 
After fasting for 20 h, two groups of ddY mice (n = 6) were given CE-one at dose of 40 
and 80 mg/kg body weight, respectively, together with glucose (2 g/kg body weight) by oral 
administration. Before given CE-one and glucose, collect blood from tail as 0 min, after given 
collect blood in small tubes with heparin sodium at 30, 60, 90, and 120 min, respectively. 
Control group (n = 6) was given 1% CMC together with glucose. The blood glucose level of 
each group was measured with the same method as above. After given CE-one and glucose, 
collect the feces of each group (0 - 2 h and 2 - 6 h). After feces were dried and the feces total 
weight of each group was obtained. The feces were first dissolved in 2 mL water, then extracted 
with same volume of EtOAc for 3 times. After collecting the EtOAc layer, it was concentrated 
to dry, then the CE-one in the feces was analyzed by proton NMR. 
5.2.4 Antihyperglycemic activity of CE-one in STZ-induced diabetic mice 
After fasting for 20 h, ICR mice were injected with 100 mg/kg STZ by single 
intraperitoneal injection (STZ dissolved in citrate buffer, pH = 4.3, prepare freshly and inject 
within 20 min). Normal control group was injected with citrate buffer (Group 1, NC, n = 5). 
Two weeks later, measure the fasting blood glucose (more than 200 mg/dL means diabetes). 
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The diabetic mice were divided into 4 groups randomly (n = 5). Group 2: Diabetes control (DC); 
Group 3: Low dose of CE-one, 20 mg/kg body weight (CL); Group 4: High dose of CE-one, 40 
mg/kg body weight (CH); Group 5: Positive control group, metformin, 250 mg/kg body weight 
(PC). The samples were given to mice by oral administration every day (Normal control group 
and diabetes control group were given 1% CMC). The experiment continued for 5 weeks. The 
fasting blood glucose (FBG), body weight, food intake and water consumption were measured 
every week. 
Finally, after fasting for 12 h, the mice were sacrificed. The blood was harvested and 
centrifuged at 8000 rpm for 3 min to obtain plasma (stored at -60˚C for further biochemical 
analysis). The weight of liver and kidneys were measured, and small part of liver was used to 
measure glycogen according to previous method (Hideo, et al., 2012). Fasting plasma insulin 
(FIN) was determined by using an ELISA kit (Morinaga, Yokohama, Japan). Total cholesterol 
(TC), triglyceride (TG), alanine transaminase (ALT) and aspartate transaminase (AST) were 
determined by commercial assay kit (Fujifilm Wako Pure Chemical Corporation, Osaka, Japan). 
All the above indicators were operated according to the guidelines of the manufacturer. The 
kidney index and liver index were calculated as below:  
Kidney, liver index (%) = 100 × weight of kidneys, liver (g) / body weight (g). 
All data are expressed as mean ± standard error (M ± SE, n = 5 - 6). The experimental data 
were analyzed by homogeneity of variance and Duncan multiple comparisons of analysis of 
variance (ANOVA) with SPSS 22.0 software (IBM Corporation, New York, USA). 
5.3 Results 
5.3.1 Results of carbohydrate-loading tests of CE-one in normal mice 
5.3.1.1 Oral maltose tolerance test (OMTT) 
As shown in Fig. 5-1A, CE-one can decrease the blood glucose level in dose dependence 
manner. The dose of CE-one at 40 mg/kg showed 17.8% decrease of blood glucose compared 
with control group at 30 min. The dose of CE-one at 80 mg/kg showed 26.7% decrease of blood 
glucose which is similar with positive control, acarbose, with 23.3% decrease. The results of 
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AUC value showed that there is no significant difference between the low and medium dose 
group of CE-one (20 and 40 mg/kg) and control group. But high dose group of CE-one (80 
mg/kg) and positive control (acarbose) both showed significant difference with control group 
(Fig. 5-1B). These results indicated that CE-one can inhibit the α-glucosidase activity in normal 
mice and suppress the blood glucose level.  
5.3.1.2 Oral starch tolerance test (OSTT) 
As shown in Fig. 5-2A, CE-one can also decrease the blood glucose level in dose 
dependence manner. The dose of CE-one at 40 and 80 mg/kg showed 33.4% and 39.2% 
decrease of blood glucose compared with control group at 30 min, respectively. The dose of 
CE-one at 80 mg/kg showed similar effect with positive control, acarbose which is 40.4% 
decrease. The results of AUC value showed that there is no significant difference between the 
low dose of CE-one (20 mg/kg) and control group. But medium and high dose group of CE-
one (40 and 80 mg/kg) and positive control (acarbose) showed significant difference with 
control group (Fig. 5-2B). These results indicated that CE-one can inhibit the α-amylase activity 
in normal mice and reduce the blood glucose level. 
5.3.1.3 Oral glucose tolerance test (OGTT) 
As shown in Fig. 5-3A, compared with control, CE-one showed no suppression on the 
blood glucose at dose of 40 mg/kg body weight. In contrast, CE-one can reduce the blood 
glucose level at dose of 80 mg/kg, with a 13.6% decrease at 30 min and a 19.9% decrease at 60 
min compared with control. The results of AUC value also showed that there is no significant 
difference at 40 mg/kg, but a significant difference at 80 mg/kg group when compared with 
control group (Fig. 5-3B). These results indicated that CE-one maybe can also inhibit the 
absorption of glucose in normal mice and lower the blood glucose level. More interestingly, 
after given CE-one to mice, the feces weight of 40 mg/kg group and 80 mg/kg group increased 
compared with control (Table 5-1). And CE-one in the feces cannot be detected within 2 h but 
can be detected during 2 - 6 h (Table 5-1). These results indicated that CE-one maybe can 
stimulate the feces excretion and it needs more than 2 h for metabolism in vivo. The detailed 
mechanisms are not elucidated in this study because of the limited time. Further studies about 
the mechanisms need to be carried on in the future. 
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5.3.2 Results of antihyperglycemic activity of CE-one in STZ-induced diabetic mice 
At the end of the experiment, the body weight of NC group was 47.92 ± 0.82 g while DC 
group showed a significant weight loss (Table 5-2). Compared with DC group, the body weight 
of CL, CH and PC groups showed no difference. These results indicated that CE-one and 
metformin cannot improve the condition of body weight. The food intake and water 
consumption of diabetes control group showed significant increase when compared with NC 
group with 6.41 ± 0.32 g and 5.62 ± 0.28 g, respectively. Compared with DC group, the food 
intake and water consumption of CL, CH, and PC groups showed significant decrease (Table 
5-2). The fasting blood glucose of NC group was 66.04 ± 3.67 mg/dL while the DC group was 
405.08 ± 66.87 mg/dL. The blood glucose level of PC group showed significant decrease. After 
given CE-one, the blood glucose level of CL, CH groups also significantly decreased (Table 5-
2). These results indicated that CE-one can improve the diabetes condition with less food intake 
and water consumption. 
As shown in Table 5-3, the kidney index and liver index of DC group showed significant 
increase compared with NC group. After given CE-one, the liver index decreased while the 
kidney index showed no difference compared with DC group. However, both kidney index and 
liver index of PC group showed no difference compared with DC group. This result indicated 
that the positive control, metformin maybe cannot improve the liver and kidney conditions. But 
CE-one can improve liver condition while it has no effect on kidneys. 
As shown in Table 5-4, compared with NC group, the insulin level and glycogen content 
of DC group were decreased significantly. CE-one and metformin had no effect on the insulin 
level but can increase the glycogen content in diabetic mice. Compared with NC group, both 
ASL level and ALT level of DC group were increased significantly. After given CE-one, the 
ASL level decreased significantly while ALT level had no change compared with DC group 
(Table 5-4). The PC group showed the similar results. These results indicated that CE-one can 
improve AST level of liver and increase the content of liver glycogen while have no effect on 
insulin level. 
As shown in Table 5-5, the TC level of DC and PC groups showed no difference with NC 
group. Compared with DC group, the TC level of CL and CH groups showed significant 
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decrease. The TG level of DC group showed significant decrease compared with NC group. 
After given CE-one, the TG levels of CL and CH groups showed no difference with DC group. 
In addition, the TG level of PC group also showed no difference compared with DC group. 
These results indicate that CE-one can reduce the TC level but has no effect on TG level in 
diabetic mice. 
5.4 Discussion 
α-Glucosidase and α-amylase are enzymes that can hydrolyze maltose and starch, releasing 
glucose. Therefore, blood glucose level after oral administration of maltose or starch indirectly 
reflects the activities of α-glucosidase or α-amylase. Our results of OMTT and OSTT suggested 
that oral administration of CE-one significantly restrained postprandial hyperglycemia in 
normal mice. These are in accordance with our in vitro results in chapter 4. One report showed 
that the similar compound, isoCE-one can inhibit the α-glucosidase and α-amylase activities 
and inhibit the formation of advanced glycation end products in a BSA-fructose model (Sheng, 
et al., 2017). The results of OGTT also showed CE-one can suppress the blood glucose level at 
dose of 80 mg/kg. This indicated that CE-one maybe can also inhibit the glucose absorption in 
normal mice. Regulation of glucose uptake is critical for treatment of metabolic syndrome as 
well as diabetes. Some reports showed that ursane-type triterpenoids, such as corosolic acid, 
ilekudinol B, ursolic acid and pomolic acid, from Weigela subsessilis, might enhance glucose 
uptake by acting as insulin mimics and as insulin sensitizers (Lee & Thuong, 2010). Besides, 
regulation of glucose transporter gene expression is an important mechanism in the regulation 
of glucose uptake in animal cells. Glucose transport in adipocytes is regulated by facilitative 
glucose transporters, GLUT1 and GLUT4 (Scheepers, et al., 2004). Pachymic acid, one of the 
lanostane-type triterpenoids, can stimulate glucose uptake, GLUT4 gene expression and 
translocation (Huang, et al., 2010). More interestingly, CE-one can increase the amount of feces. 
The mechanism remains unclear. Maybe it can stimulate the intestinal cells movement or inhibit 
the lipid absorption then increase the frequency of defecation. More experiments need to be 
done to clarify the detailed mechanisms in the future. 
During treatment of samples for 5 weeks, FBG, food intake and water consumption of 
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STZ-induced diabetic mice were significantly higher than those of normal mice, while body 
weight was prominently lower than that of normal mice. These characteristics were similar to 
the characteristics of hyperglycemia, weight reduction, polydipsia and polyphagia in patients 
with diabetes (Ashcroft & Rorsman, 2012). After five weeks treatment of CE-one, FBG, food 
intake and water consumption significantly decreased compared with DC group while body 
weight remains no change. These results indicated the diabetes condition was improved by CE-
one. 
Liver plays a crucial role in energy balance because it is one of the most important places 
to regulate glucose metabolism and maintain a dynamic balance of the blood glucose 
concentration (Maleki, et al., 2019). It is the main site for regulating glucose absorption, 
glycogen synthesis, and gluconeogenesis and makes a momentous role in maintaining blood 
glucose metabolism and energy balance (Han, et al., 2019). Consequently, the degree of liver 
injury and the amount of liver glycogen synthesis indirectly reflect the insulin activity and 
glucose metabolism ability of the body (Ren, et al., 2019). Generally, the levels of AST and 
ALT are detected together to evaluate the liver damage (Hanley, et al., 2004). In this study, the 
contents of AST and ALT in plasma and liver index of diabetic mice were significantly 
increased, indicating that hyperglycemia led to severe liver injury, and the content of liver 
glycogen was significantly reduced in comparison to that of normal mice. However, five weeks 
of CE-one treatment significantly improved liver index, prominently reduced the AST level in 
plasma and significantly increased the content of liver glycogen in diabetic mice, thereby 
indicating that CE-one regulated the blood glucose level by improving the condition of liver 
injury and promoting the production of glycogen in diabetic mice (Li, et al., 2019). The research 
of Mosa and Khalil indicated that consumption of fresh and dried banana peels may modify the 
risk of acute liver failure of rats (Mosa & Khalil, 2015). Some other reports also showed that 
triterpenoids can restrain the high levels of ALT and AST and exhibit hepatoprotective effect 
in mice, which related to its effect of anti-oxidation and anti-inflammation. (Yin, et al., 2019; 
Liu, et al., 2020).  
The level of glucose is also regulated by hepatic glycogen phosphorylase (GP) catalyzing 
glycogenolysis leading to an increased hepatic glucose output and glycogen synthase, which 
stimulates gluconeogenesis (Tahrani, et al., 2011). It has been stated that inhibition of hepatic 
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GP has the potential to be an effective therapy for attenuating hyperglycemia associated with 
type 2 diabetes (Baker, et al., 2005). Among triterpenes, oleanane derivatives were mostly 
reported as potential GP inhibitors, such as oleanolic acid, hederagenin, tormentic acid, asiatic 
acid, corosolic acid and maslinic acid (Luo, et al., 2008; Yang, et al., 2010; Wen, et al., 2005). 
It was also reported that liver had the highest bioavailability for triterpene compared with other 
tissues and it is the major organ for triterpene storage and/or metabolism (Yin, et al., 2012). 
This is in accord with our results that CE-one mainly exert the effect on liver. Moreover, the 
kidney index and the level of insulin in diabetic mice remained no change indicated that CE-
one maybe cannot improve kidneys condition and insulin secretion in vivo.  
In addition, our results also showed that CE-one can reduce the level of cholesterol in 
plasma. This is consistent with the reports that triterpenes have anti-hyperlipidemic activity 
(Machaba, et al., 2014; Musa, et al., 2019). Triterpene treatment possesses therapeutic effects 
on diet-induced hyperlipidemia by inhibiting the intestinal absorption and storage of cholesterol. 
The reason is their structural similarity with cholesterol, these compounds can interfere with 
the solubilization of cholesterol in the gut, reducing its absorption (Liu, et al., 2007). 
5.5 Conclusion 
CE-one can exert the antihyperglycemic activity both in normal mice and STZ-induced 
diabetic mice. It can inhibit α-glucosidase and α-amylase activity and the glucose absorption in 
normal mice. The underlying mechanism of antihyperglycemic activity in diabetic mice maybe 
because of its improvement effect of liver injury and increasement of glycogen content. In 
addition, CE-one can also reduce the level of cholesterol in plasma. 
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5.6 Figures and tables 
 
 
Fig. 5-1 The results of OMTT of CE-one. A: The time course of blood glucose level. B: The 
results of AUC value. Different letters on each column indicate a significant difference at p < 
0.05. The numbers in parenthesis are the dose of samples (mg/kg body weight). The data are 





























































Fig. 5-2 The results of OSTT of CE-one. A: The time course of blood glucose level. B: The 
results of AUC value. Different letters on each column indicate a significant difference at p < 
0.05. The numbers in parenthesis are the dose of samples (mg/kg body weight). The data are 































































Fig. 5-3 The results of OGTT of CE-one. A: The time course of blood glucose level. B: The 
results of AUC value. Different letters on each column indicate a significant difference at p < 
0.05. The numbers in parenthesis are the dose of samples (mg/kg body weight). The data are 


























































Table 5-1 The results of feces weight and CE-one in feces 
Group Feces weight (mg) CE-one in feces (0-2 h) CE-one in feces (2-6 h) 
Control 31.6±5.0 - - 
CE-one (40) 44.6±6.6 - + 
CE-one (80) 49.6±5.8 - + 
Note: The symbol “-” means cannot detect CE-one. The symbol “+” means can detect CE-one. 
The data are expressed as mean ± standard error (M ± SE, n = 6). 
 
Table 5-2 Body weight, food intake, water consumption and blood glucose of mice groups 
Group Body weight (g) Food intake (g) Water consumption (g) 
Blood glucose 
(mg/dL) 
NC 47.92±0.82b 6.41±0.32a 5.62±0.28a 66.04±3.67a 
DC 38.84±0.90a 15.31±0.76d 56.79±1.32d 405.08±66.87c 
CL 36.08±1.36a 12.54±0.61c 46.23±1.98c 256.98±21.63b 
CH 37.69±1.56a 11.18±0.72bc 46.99±2.00c 203.54±28.08b 
PC 35.56±1.11a 9.40±0.86b 35.93±3.96b 249.25±43.92b 
Note: Different letters in each column indicate a significant difference at p < 0.05. The data are 
expressed as mean ± standard error (M ± SE, n = 5). 
 
Table 5-3 Kidney and liver index of mice groups 
Group Kidney index (%) Liver index (%) 
NC 1.38±0.06a 3.67±0.08a 
DC 1.97±0.06b 4.42±0.20b 
CL 1.95±0.20b 3.83±0.23a 
CH 1.81±0.07b 4.17±0.12ab 
PC 1.90±0.08b 4.49±0.19b 
Note: Different letters in each column indicate a significant difference at p < 0.05. The data are 















NC 0.25±0.05b 31.51±5.17c 271.00±46.74a 20.34±1.08a 
DC 0.06±0.02a 3.07±0.49a 752.77±62.24c 55.88±11.86b 
CL 0.06±0.01a 5.85±1.47a 557.45±74.29bc 54.04±4.66b 
CH 0.07±0.04a 10.97±3.72ab 427.55±95.23ab 46.34±7.95b 
PC 0.06±0.02a 19.17±6.11bc 609.15±53.57bc 56.63±10.97b 
Note: Different letters in each column indicate a significant difference at p < 0.05. The data are 
expressed as mean ± standard error (M ± SE, n = 5). 
 
Table 5-5 TC and TG levels of mice groups 
Group TC (mg/dL) TG (mg/dL) 
NC 156.9±7.9b 96.9±8.0b 
DC 154.0±8.6b 44.3±12.0a 
CL 107.4±9.3ab 43.2±12.9a 
CH 93.6±11.0a 45.1±14.1a 
PC 155.9±15.6b 60.2±11.5a 
Note: Different letters in each column indicate a significant difference at p < 0.05. The data are 
expressed as mean ± standard error (M ± SE, n = 5). 
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Chapter 6 Stability of cycloeucalenone in vitro and in vivo 
6.1 Introduction 
The stability of triterpenes is very important for its bioavailability and application. 
However, triterpenoids are usually unstable and can be converted into other triterpenoids during 
the processing (Tai, et al., 2019). In order to develop more utilization of CE-one in different 
industry and investigate its bioavailability in body, the stability of CE-one had been investigated 
in vitro and in vivo in this chapter. 
6.2 Materials and methods 
6.2.1 Stability of CE-one in vitro 
6.2.1.1 HPLC conditions and standard cure of CE-one 
HPLC conditions are as follows: column: ODS-HG-5 (4.6 × 250 mm); column temperature: 
40˚C; mobile phase: 100% MeOH; flow rate: 1 mL/min; time: 20 min; sample volume: 50 μL; 
PDA detector: 204 nm; pressure: 7.8 MPa. 
Around 1 mg of CE-one was dissolved in 100% MeOH to prepare 1000 μg/mL CE-one. It 
was diluted to 1, 2, 4, 8, 16, 32, 64, 128, and 256 μg/mL. The standard samples were analyzed 
by HPLC. 
6.2.1.2 Thermal stability of CE-one 
To simulate different processing conditions, 37˚C (24 h), 60˚C (12 h and 24 h), 100˚C (1 
h), 200˚C (0.5 h) were chosen to investigate the thermal stability. Around 1 mg of CE-one was 
weighed in each dry bottle, after kept under these conditions, they were dissolved in 1 mL 100% 
MeOH. After dilution by 10 times, samples were analyzed by HPLC (each condition was 
performed in triplicate). 
6.2.1.3 Stability of CE-one in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) 
a. Preparation of SGF (without pepsin) 
SGF was prepared as described in pervious report (Fu, et al., 2002), with slight 
modification. Dissolve 100 mg of sodium chloride (NaCl) in moderate water. Add 1 M 
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hydrochloric acid (HCl) and sufficient water to make 50 mL. The final pH of this solution is 
about 1.2.  
b. Preparation of SIF (without pancreatin) 
SIF was prepared as described in pervious report (Fu, et al., 2002), with slight modification. 
Dissolve 340 mg of monopotassium phosphate (KH2PO4) in moderate water. Add 1 M sodium 
hydroxide (NaOH) and sufficient water to make 50 mL. The final pH of this solution is about 
6.8. 
c. Preparation of samples 
First, 200 μg/mL of CE-one in 100% DMSO was prepared. Then 25 μL CE-one solution 
was taken and mixed with 475 μL SGF, SIF or water and kept at 37˚C for 0 h, 2 h, 4 h (Water 
was used as control). After extracted with EtOAc for 3 times, the EtOAc layer was collected 
and evaporated to dry. After dissolved in 200 μL 100% MeOH, samples were analyzed by 
HPLC (each condition was performed in triplicate).  
The remaining rate (%) = 100 × Actual concentration / Initial concentration 
6.2.2 Stability of CE-one in normal mice 
After fasting for 20 h, four groups (n = 3) of ddY mice were used. Group 1: after the mice 
were sacrificed, the blood was collected and the part from the top of stomach to the bottom of 
small intestine was taken, then 40 mg/kg body weight CE-one was injected from the top of this 
part directly. Group 2, 3, 4: after oral administration of 40 mg/kg body weight CE-one for 0.5 
h, 1.0 h, 2.0 h, respectively, then the mice were sacrificed and the blood and same part from the 
top of stomach to the bottom of small intestine were taken.  
The taken part was washed with 20 mL normal saline, and the content inside the stomach 
and small intestine was collected. The content was extracted with 20 mL EtOAc for 2 times. 
After EtOAc layer was evaporated to dry, it was dissolved with 0.5 mL 100% MeOH. After 
centrifuge, the supernatant was collected and evaporated to dry again. After dissolved in 0.70 
mL CDCl3, samples were analyzed by proton NMR. In addition, the plasma of each mouse was 
extracted with EtOAc for 3 times. After the supernatants were collected and evaporated to dry, 
they were also analyzed by proton NMR. For each sample, the solvent CDCl3 was used as 
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reference. And the specific proton signal at 4.69 ppm was used to define CE-one. The relative 
amount of CE-one was calculated as below: CE-one (%) = 100 × integrate of proton signal at 
4.69 ppm / integrate of residual proton signal of CDCl3. The Group 1 was defined as control 
group, which means the content of CE-one is 100% in stomach and small intestine, 0% in 
plasma. 
All data are expressed as mean ± standard deviation (M ± SD, n = 3). The experimental 
data were analyzed by homogeneity of variance and Duncan multiple comparisons of analysis 
of variance (ANOVA) with SPSS 22.0 software (IBM Corporation, New York, USA). 
6.3 Results  
6.3.1 Stability of CE-one in different temperatures, SGF and SIF 
The various concentrations of CE-one as standard samples were analyzed by HPLC for 
the following quantitative analysis. All different concentrations of CE-one showed the retention 
time with range from 12.330 to 12.370 min. The minimum concentration of CE-one for 
detection was 1 µg/mL. The linearity was confirmed at the concentrations below 256 µg/mL 
under these conditions. The typical series of concentrations for standard curve of CE-one (1 
μg/mL - 256 μg/mL, n=1) were shown in Fig. 6-1 as chromatograph and in Fig. 6-2 as standard 
curve. The peak area of CE-one showed in a concentration-dependent manner. The R2 of 
standard cure is 0.9993 which demonstrates its high reliability. The retention time and peak area 
of different concentrations of CE-one standard samples were shown in Table 6-1. 
The HPLC results of CE-one under different temperatures were shown in Fig. 6-3. For the 
thermal stability, there are some other peaks appeared at 100˚C, especially 200˚C. In contrast, 
nearly no other peaks appeared below 60˚C (Fig. 6-3). Under 100˚C for 1 h and 200˚C for 0.5 
h, the remaining rate of CE-one are 82.26 ± 2.55% and 26.14 ± 3.44%, respectively (Table 6-
2). They have significant differences compared with below 60˚C (Table 6-2). The remaining 
rate of CE-one was more than 93% below 60˚C and had no significant difference (Table 6-2). 
These results indicated that CE-one is stable below 60˚C and not stable beyond 100˚C, 
especially 200˚C.  
The HPLC results of CE-one in SGF, SIF and water are shown in Fig 6-4, Fig 6-5, Fig 6-
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6, respectively. For SGF, after keep 2 h and 4 h at 37˚C, the relative remaining rate of CE-one 
are 84.56 ± 2.92% and 75.83 ± 2.82%, respectively (Table 6-3). For SIF, after keep 2 h and 4 h 
at 37˚C, the relative remaining rate of CE-one are 85.40 ± 0.36% and 76.57 ± 1.58%, 
respectively (Table 6-3). For water, after keep 2 h and 4 h at 37˚C, the relative remaining rate 
of CE-one are 90.86 ± 1.30% and 89.04 ± 1.20%, respectively (Table 6-3). The relative 
remaining rate of CE-one in SGF, SIF and water are decreased as the keeping time increased. 
There are significant differences between 2 h and 4 h in SGF and SIF. In contrast, there is no 
difference between 2 h and 4 h in water (Table 6-3). Compared with water, the relative 
remaining rate of 2 h and 4 h in SGF and SIF showed significant difference (Table 6-3). All 
these results indicated that CE-one can decrease in SGF and SIF over time, and it is easier to 
decrease in SGF and SIF than in water. But the stability of CE-one in SGF and SIF is relatively 
high, around 75% still remains after 4 h. 
6.3.2 Stability of CE-one in different parts of normal mice 
As shown in Table 6-4, after oral administration of CE-one for 0.5 h, 1.0 h, and 2.0 h in 
normal mice, the relative amount of CE-one in the content of stomach and small intestine were 
89.46 ± 7.62%, 81.83 ± 9.49% and 77.09 ± 9.12%, respectively. It was found that the relative 
amount of CE-one had a time-dependent manner. With the increasing of time, the amount of 
CE-one decreased gradually. At 0.5 h and 1.0 h, there is no significant difference. But at 2.0 h, 
there is a significant difference. This indicated that after 2 h, CE-one will have a significant lose 
in normal mice. But most part of CE-one (around 77%) still remains in stomach and small 
intestine after given CE-one for 2 h. In contrast, the CE-one cannot be detected in plasma. This 
maybe because of the amount of CE-one in plasma lower than limit of detection of proton NMR. 
6.4 Discussion 
CE-one is one of cycloartane-type triterpenes which is abundant in banana peel. There 
have been no reports about the stability of CE-one until now. Some reports indicated that the 
melting point of CE-one is 83 - 84˚C (Kongkathip, et al., 2002), and the boiling point is 
predicted to be over 500˚C. It was reported that 70˚C (or lower) was the best drying temperature 
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of Rhizoma Alismatis to obtain triterpenoids because of the obvious destruction of chemical 
composition when dried over 80˚C (Tai, et al., 2019). This is in accordance with our results that 
CE-one is stable below 60˚C. One report showed that a pentacyclic triterpene which was 
extracted from Centella asiatica was stable over a period of four months when stored as a dried 
powder in a well-closed container kept out of light at 4˚C (Puttarak, et al., 2016). In this study, 
the stability of CE-one is high below 60˚C and low beyond 100˚C, especially 200˚C. This 
indicated that CE-one can be used as ingredient for functional food but cannot used for baked 
food. Under SGF (pH 1.2) and SIF (pH 6.8) condition, CE-one is relatively stable. There are 
still around 75% of CE-one remains after keep in SGF and SIF for 4 hours. This indicated that 
CE-one with intact form is stable in acidic or neutral conditions. The aqueous alcoholic solution 
of one pentacyclic triterpene was stable at pH values of 5.8 and 7.0 but was not stable at a pH 
of 8.2 (Puttarak, et al., 2016). This report is similar with our results which showed that CE-one 
is relatively stable in acidic or neutral conditions. All these results indicated that CE-one is 
relatively stable in vitro, the stability in vivo also need to be evaluated in next part. 
The stability of triterpenes in vivo is important to exert their bioactivities. In our results, 
after oral administration of CE-one for 2 h in normal mice, there are still around 77% of relative 
amount remains in the content of stomach and small intestine. This indicated that most of CE-
one did not change the intact form, its stability is relatively high in vivo. CE-one cannot be 
detected in plasma indicated that with intact form it maybe not easy to absorute from intestine 
wall. This complied with triterpenes are large molecules and their penetration through cell 
membranes can be difficult. However, permeability models with Caco-2 cell monolayer 
indicated that some triterpenes, such as lupeol, oleanolic acid, ursolic acid, asiatic acid and 
boswellic acid, can pass the intestinal epithelium (J. C. Furtado, et al., 2017). Besides, triterpene 
absorption can be enhanced by high fat meals and triterpene bioavailability can be improved by 
increasing the poor solubility in the gastrointestinal fluid and their absorption, or by inhibiting 
their metabolism (J. C. Furtado, et al., 2017). In addition, it has been observed that the 
bioavailability of triterpenes can be improved by combining them with cyclodextrins (Cerga, et 
al., 2011). CE-one combined with cyclodextrins maybe one option to improve its bioavailability 
in the future. In the present research, the stability of CE-one is stable both in vitro and in vivo 
which indicated that it is maybe one good ingredient for functional food. And the thermal 
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stability of CE-one also provides the possibility of using oven to dry the banana peel and 
produce CE-one on a large scale in industry. 
6.5 Conclusion 
The stability of CE-one is relatively high both in vitro and in vivo. CE-one is stable below 
60˚C and not stable beyond 100˚C, especially 200˚C. CE-one can be used as ingredient for 
functional food but cannot used for baked food. It is also relatively stable in SGF and SIF 
condition. There are still around 75% of CE-one remains after keep in SGF and SIF for 4 hours. 
After oral administration of CE-one for 2 h in normal mice, there are still around 77% of relative 
amount remains in the content of stomach and small intestine. To the best of our knowledge, 
the present study is the first report about the stability of CE-one in vitro and in vivo. The present 
study provides some evidence of CE-one for food processing and effectivity in intestine as 
health promoting ingredient. This will provide some valuable information for utilization of CE-
























Fig. 6-1 The HPLC results of CE-one standard samples. 
The retention time of peaks at around 12.5 min are CE-one with various concentrations. The 
peak area of each sample was summarized in Table 6-1. 




















































































































































































































































































Fig. 6-2 The standard curve of CE-one in HPLC. 
The concentrations of CE-one are 1, 2, 4, 8, 16, 32, 64, 128, and 256 μg/mL. 
  






































Fig. 6-3 The HPLC results of CE-one under different temperatures (one representative of 
results in triplicate). The retention time of peaks at around 12.5 min are CE-one. The 
remaining rate of each condition was summarized in Table 6-2. 
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Fig. 6-4 The HPLC results of CE-one in SGF (one representative of results in triplicate). The 
retention time of peaks at around 12.5 min are CE-one. The relative remaining rate of each 
condition was summarized in Table 6-3. 
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Fig. 6-5 The HPLC results of CE-one in SIF (one representative of results in triplicate). The 
retention time of peaks at around 12.5 min are CE-one. The relative remaining rate of each 
condition was summarized in Table 6-3. 
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Fig. 6-6 The HPLC results of CE-one in Water (one representative of results in triplicate). The 
retention time of peaks at around 12.5 min are CE-one. The relative remaining rate of each 
condition was summarized in Table 6-3. 
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Table 6-1 The retention time and peak area of different standard samples of CE-one. 
Concentration (μg/mL) Retention time (min) Peak area 
1 12.365 18910 
2 12.366 36415 
4 12.365 72175 
8 12.360 139622 
16 12.357 268312 
32 12.357 516579 
64 12.356 986712 
128 12.347 1912048 
256 12.332 3646851 
 
Table 6-2 The remaining rate of CE-one under different temperature 
Condition Remaining rate (%) 
200˚C, 0.5 h 26.14±3.44a 
100˚C, 1 h 82.26±2.55b 
60˚C, 24 h 94.07±0.98c 
60˚C, 12 h 93.04±2.90c 
37˚C, 24 h 95.72±4.61c 
Note: Different letters following each value indicate a significant difference at p < 0.05. The 
data are expressed as mean ± standard deviation (M ± SD, n = 3).  
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Table 6-3 The relative remaining rate of CE-one in SGF, SIF and water. 
Time SGF (%) SIF (%) Water (%) 
0 h 100.00±1.51Aa 100.00±0.86Aa 100.00±1.43Aa 
2 h 84.56±2.92Ab 85.40±0.36Ab 90.86±1.30Bb 
4 h 75.83±2.82Ac 76.57±1.58Ac 89.04±1.20Bb 
Note: Different letters in the same column (a, b, c) and same row (A, B) indicate a significant 
difference at p < 0.05. The data are expressed as mean ± standard deviation (M ± SD, n = 3). 
 
Table 6-4 The relative amount of CE-one in different parts of normal mice 
Group Content of stomach and small intestine (%) Plasma (%) 
1 (0 h) 100.00±10.68a - 
2 (0.5 h) 89.46±7.62ab - 
3 (1 h) 81.83±9.49ab - 
4 (2 h) 77.09±9.12b - 
Note: The symbol “-” means cannot detect CE-one. Different letters following each value 
indicate a significant difference at p < 0.05. The data are expressed as mean ± standard deviation 




Banana including dessert banana and cooking banana, is the second largest produced fruit 
after citrus. In 2018, banana production in the world was 115.74 million metric tons, which was 
about 16% of the world's total fruit output (El Barnossi, et al., 2020). Banana peel as by-product, 
which is about 35% of the total fresh weight, usually used as organic fertilizer or simply 
discarded as waste (Schieber, et al., 2001). Many studies have shown that banana peel is an 
important resource which contains many kinds of nutrients and active components (Emaga, et 
al., 2007; Pereira & Maraschin, 2015; Singh, et al., 2016). Currently, banana peel as an 
important resource has been severely underestimated. This study focused on the 
antihyperglycemic activity of triterpenes in banana peel. The purpose of this research is to 
develop potential antidiabetic activity of natural triterpenes in banana peel and provide an 
alternative way to take full advantage of banana peel resource.  
In this study, four triterpenes, cycloeucalenone (CE-one), 31-norcyclolaudenone (isoCE-
one), cycloeucalenol (CE-ol) and its isomer (isoCE-ol) were isolated from EtOAc extract of 
banana peel (Chapter 2). And their structures were confirmed based on the analysis of 1D and 
2D NMR (Chapter 3). The effects of these triterpenes on carbohydrate digestive enzymes were 
investigated in vitro to elucidate their structure-activity relationships and kinetic property of 
CE-one (Chapter 4). To confirm effects of the triterpenes in vivo, the major triterpene, CE-one 
was evaluated in carbohydrate loaded mice and STZ-treated diabetic model mice (Chapter 5). 
In addition, the physical and physiological stabilities of CE-one were investigated under the 
conditions for food processing and the conditions in digestive tract, respectively (Chapter 6). 
Banana peel as by-product has been studied for many years. It has been reported that 
phytosterols represent majority of the lipophilic extract of banana peel with CE-one, isoCE-one, 
stigmasterol, β-sitosterol, and campesterol as the major components (Oliveira, et al., 2008; 
Villaverde, et al., 2013). In this study, CE-one and isoCE-one were also found to be the major 
triterpenes in banana peel. In addition, CE-ol and isoCE-ol were isolated from banana peel for 
the first time. The α-glucosidase and α-amylase are important enzymes of dietary carbohydrate 
digestion in our body. Inhibitors of these enzymes are effective in delaying carbohydrate 
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digestion and glucose absorption to suppress postprandial hyperglycemia (Tadera, et al., 2006). 
Our results of in vitro experiments indicated that CE-one and isoCE-one possess much stronger 
α-glucosidase and α-amylase inhibitory activities than CE-ol and isoCE-ol and the main active 
site of them is the carbonyl group at C-3 rather than hydroxy group at C-3. And the double bold 
in the side chain can also affect these activities. CE-one and isoCE-one exhibited both α-
glucosidase and α-amylase inhibitory activities in vitro. And CE-one showed higher α-
glucosidase and α-amylase inhibitory activities than that of isoCE-one. In contrast, CE-ol and 
isoCE-ol had insufficient inhibitory activity against either enzyme. The IC50 values of CE-one 
and isoCE-one against α-glucosidase were 31.83 ± 2.46 μM and 38.85 ± 1.54 μM, respectively, 
and their IC50 values against α-amylase were 20.33 ± 0.59 μM and 27.63 ± 0.83 μM, 
respectively. The main active sites of CE-one and isoCE-one are the carbonyl group at C-3 and 
double bond in the side chain. And CE-one induced a parabolic mixed-type inhibition with the 
Ki value of 73.86 μM in α-glucosidase inhibitory assay. 
Besides, our results of in vivo experiments also indicated that CE-one can exert the 
antihyperglycemic activity in carbohydrates (starch, maltose, or glucose) loaded mice. It can 
inhibit α-glucosidase and α-amylase activity and the glucose absorption in normal mice. The 
results of CE-one in STZ-induced diabetic mice indicated that CE-one can decrease the blood 
glucose level, food intake, water consumption and liver index. CE-one cannot affect the body 
weight, kidney index, and insulin level of diabetic mice. In addition, CE-one can also decrease 
total cholesterol level in plasma while has no effect on triglyceride level. The main effect of 
CE-one are inhibition of α-glucosidase and α-amylase activities and improvement of liver injury 
condition. There are some studies have been reported about the antihyperglycemic activity of 
banana peel. The methanol extract of banana peel can effectively lower blood glucose level of 
mice in oral glucose tolerance test which showed similar effect with glibenclamide at the 
highest dose (Hossain, et al., 2017). It also exerted more potent in α-amylase inhibitory activity 
than that of Citrus limon, Punica granatum (Vasu, et al., 2017). The ethyl acetate extract of 
banana peel also displayed potent antihyperglycemic activity in alloxan-induced diabetic mice 
and further results indicated that lupenone is the effective ingredient (Wu et al., 2015). In 
addition, umbelliferone and lupeol in banana flower also exerted antihyperglycemic activity in 
vitro and in vivo (Ramu, et al., 2014; Ramu, et al., 2016). The present study indicated that CE-
64 
one, the natural compound with low toxicity in banana peel, maybe can be used as one of 
candidates for treatment and/or prevention of diabetes in the future.  
Moreover, the stability of CE-one was investigated in vitro and in vivo. It was reported that 
the chemical composition of triterpenoids usually will be destroyed obviously when dried over 
80˚C (Tai, et al., 2019). Our results indicated that the thermal stability of CE-one is stable below 
60˚C and not stable beyond 100˚C, especially 200˚C. This will provide some important 
reference values for the industrial production of CE-one in banana peel. For the utilization of 
by-product, one of the important steps is drying process. The very common and cheap drying 
method is driven by solar energy or oven. Our results indicated that this common drying method 
can be used to produce CE-one (below 60˚C). In addition, CE-one can also be used as one of 
the ingredients for functional food. But it cannot be used as the ingredient for baked food 
because of its processing temperature usually higher than 200˚C. The stability of CE-one in 
SGF and SIF indicated that it is relatively stable in acidic or neutral conditions. There are still 
around 75% of CE-one remains in SGF and SIF after 4 hours. Furthermore, after oral 
administration of CE-one for 2 h in normal mice, there are still around 77% of relative amount 
remains in the content of stomach and small intestine. Our results indicated that CE-one is a 
good candidate as the potential antidiabetic agent. 
The present study showed the antihyperglycemic activity and mechanisms, and the 
stability of CE-one in vitro and in vivo. It not only provides the possibility to use CE-one as 
potential antidiabetic agent, but also provides an alternative method to recycle banana peel 
resource. Nevertheless, further studies about the absorption and metabolism of CE-one in vivo 
and more direct evidence of antihyperglycemic mechanisms in vivo still need to be investigated 
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Fig. 24 DEPT 135 (top) and DEPT 90 (bottom) for isoCE-ol (150 MHz NMR in CDCl3). 
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